Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
12/2015 not set
Aespira
Aespira Overview
Aespira is developing a pipeline of inhaler products using generic drugs. Aespira's inhalers help prevent contamination, are simple to use by non-trained patients, and facilitate single-dose or non-chronic usage.
The company has developed the ActiveMesh technology, a method of packaging dry-powder drugs within a mesh-based package. The breath-driven beating of this package causes it to sieve and release fine dry-powder particles with diameters in the respirable range. The integration of this technology provides an active dispersion mechanism to a passive inhaler.
Aespira is also developing a disposable and hygienic whistle-shaped inhaler devicecalled the resQhaler, which uses the airflow though the device fromthe inhalation action of the patient to efficiently beat the ActiveMesh package. This approach ensures effective breath-synchronized drug delivery with audible confirmation.